Efficacy of disitamab vedotin in non-small cell lung cancer with HER2 alterations: a multicenter, retrospective real-world study

ABSTRACT:

SUBMITTER: Zhang M 

PROVIDER: S-EPMC11576286 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature